Patient: doctor chen! In July 30th, the patients underwent bilateral subtotal thyroidectomy, the right papillary thyroid carcinoma, 1.5*1.2*
Patient: doctor chen! In July 30th, the patients underwent bilateral subtotal thyroidectomy, the right papillary thyroid carcinoma, 1.5*1.2*0.8cm, the left side of the tumor, and the neck lymph node dissection of VI, no lymph node metastasis. After surgery, take a good music, every morning and evening. Does this situation need to do I131 treatment? Thank you for your reply!
Shanghai No.6 People's Hospital of nuclear medicine Chen Libo: your situation needs to be iodine -131 ablation therapy. According to the domestic and foreign relevant guidelines for diagnosis and management of thyroid diseases, differentiated thyroid carcinoma (papillary carcinoma and follicular carcinoma) underwent total thyroidectomy or subtotal resection in patients after conventional response to iodine -131 ablation to eliminate possible hidden cancer and metastatic foci, and thyroglobulin (Tg) has become a reliable tumor in order to facilitate follow-up markers. In the past clinical work, we often encounter patients with thyroid cancer without recurrence or metastasis after -131 ablation. At present, due to the publication of these guidelines and the deepening of the understanding of this treatment, iodine -131 ablation has become a routine treatment for thyroid cancer.
But someone think that scholars and research institutions: the maximum diameter of not more than 1 cm solitary papillary thyroid carcinoma (Zhuang microcarcinoma) and without any of the following situations can not be iodine -131 ablation, including: 1 2 thyroid capsule invasion; metastasis; 3 radiation history; 4 cells and columnar cells, poor histology showed diffuse sclerosis.
Reference: Luster M, Clarke SE, Dietlein M, Lassmann M, Lind P, Oyen WJ, Tennvall J, Bombardieri E. Dietlein Guidelines for radioiodine therapy of differentiated thyroid cancer.Eur J Nucl Med Mol Imaging. 2008; 35 (10): 1941-59.
Chen Libo, Shanghai City Youth Science and technology star, Shanghai No.6 People's Hospital of nuclear medicine, chief physician, professor in Germany, MD, PhD, the official journal of the American Thyroid Association "Thyroid" invited reviewer, a visiting fellow at Yokohama University of japan. With unique and rich experience in the diagnosis and treatment of thyroid disease, especially in differentiated thyroid carcinoma (pathology of papillary or follicular thyroid carcinoma) for comprehensive diagnosis and treatment with or without lymph node, lung and bone metastasis. So far, more than one thousand cases of thyroid cancer patients, has achieved significant results. At present, it is focused on the clinical diagnosis and treatment of lung metastatic thyroid cancer. Won the World Association of nuclear medicine and Biology (WFNMB) "outstanding contribution award", the Japanese Society of nuclear medicine "Asian Young Investigator Award, Shanghai science and Technology Commission of medical science and Technology Award", Shanghai City Board of education "doctoral outstanding achievement award" and "Shanghai No.6 People's Hospital clinical medical achievement award. Has been selected Shanghai Youth Science and technology star, Shanghai Jiaotong University School of Medicine, hundred people plan and Shanghai No.6 People's Hospital, young technical backbone and other personnel training program. As the first author in the "J Nucl Med" (the United States, SCI, IF=7), "Nucl Med Biol" (the United States, SCI, IF=2), "J Thromb Thrombolys" (Holland, SCI, IF=2), "Nuclear Science and Techniques (EI)", "Chinese Journal of Endocrinology and metabolism," and other famous professional the Journal of academic papers published about 40 papers, one monograph "radionuclide therapy". As the first responsible person, at present the foundation of the National Natural Science Foundation, Shanghai Municipal Science and Technology Commission, Shanghai Municipal Health Bureau and Shanghai Jiao Tong University and other institutions funded and clinical research projects 4, a number of participating in scientific research.
Outpatient information and reservation:
The 1 international medical clinic: Friday afternoon, 10 limit, limit of thyroid Difficult miscellaneous diseases (such as refractory hyperthyroidism, refractory thyroid cancer) diagnosis, PET/SPECT/CT imaging diagnosis of difficult cases, and high-end foreign demand, 13 outpatient building international medical department registration (508 yuan), with 15 floors of the consulting room when the week, telephone booking: 021-64837019, 021-24056318 or 021-24056286. 2 VIP Clinic: Thursday morning, 20 limit, limit of hyperthyroidism (referral), thyroid carcinoma, thyroid nodules, fertility related thyroid disease, 13 outpatient building special outpatient registration (208 yuan), with 14 floors of the consulting room, within 6 weeks of the telephone booking: 021-54972001 or 021-24058613. Successful appointment can be registered through the 13 terminal self-service terminal and pay (starting at 7 a.m.), convenient and quick. 3 expert consultation: Tuesday afternoon and Thursday afternoon, the 30 number limit (diagnosed), diagnosis and treatment of Hyperthyroidism Hypothyroidism, thyroid nodules, thyroid carcinoma and metastatic bone tumor, 1 outpatient building expert registration window (31 yuan), consulting room, No. 12 10 floor B District, within 6 weeks of the telephone booking: 021-64757781 021-64757782, or 021-24056666. 4 telephone consultation: non office hours and Dr. Chen Libo I call. Call 4008-900-120 to 3 make an appointment, please call before fully prepared (Mandarin narrative history, mainly for the inspection and clear question) to save cost and improve efficiency, consulting fees 300 yuan / times (maximum 15 minutes).